Abiologics is surpassing the limits of biology by leveraging artificial intelligence and chemistry to create Synteins™, a new class of supranatural and programmable biologics that aims to redefine what therapeutics can achieve for patients across a range of disease areas.
Existing biologic medicines have resulted in tremendous improvements for the treatment of many diseases. However, these therapeutics have limitations that compromise their potential. Abiologics is creating a new generation of biologics that surpass the limitations of today’s medicines.
About UsThe Abiologics platform leverages cutting-edge generative AI and high-throughput chemical protein synthesis to computationally design and chemically synthesize supranatural biologics. These programmable medicines are endowed with extraordinary properties to bring life-changing treatments to people across a wide range of diseases.
Learn MoreToday’s scientific advances are enabling us to imagine and create therapeutics crafted from artificial building blocks that are inaccessible to nature, yet compatible with human biology. At Abiologics, we are developing medicines of the future, designed with purpose to transform how diseases are treated.
